News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,420 Results
Type
Article (1095)
Company Profile (3)
Press Release (37213)
Section
Business (14017)
Career Advice (13)
Deals (2921)
Drug Delivery (2)
Drug Development (3184)
Employer Resources (3)
FDA (562)
Job Trends (638)
News (18362)
Policy (1515)
Tag
2027 Pharm Country Standard (1)
Academia (61)
Accelerated approval (2)
Allergies (1)
Alliances (2622)
ALS (9)
Alzheimer's disease (111)
Antibody-drug conjugate (ADC) (13)
Approvals (576)
Artificial intelligence (48)
ASCO (9)
Autoimmune disease (12)
Automation (1)
Bankruptcy (21)
Belgium (2)
Best Places to Work (376)
BIO (6)
Biologics (1)
Biosimilars (4)
BioSpace Insights (1)
Biotechnology (16)
Bispecific (1)
Bladder cancer (8)
Brain cancer (3)
Breast cancer (76)
Cancer (285)
Cardiovascular disease (10)
Career advice (12)
CAR-T (1)
CDC (1)
Cell therapy (26)
Clinical research (2696)
Collaboration (107)
Compensation (11)
Complete response letters (1)
COVID-19 (229)
CRISPR (1)
C-suite (75)
Cystic fibrosis (3)
Data (272)
Depression (7)
Dermatology (1)
Diabetes (11)
Diagnostics (454)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (29)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (4590)
Employer resources (3)
Events (4980)
Executive appointments (71)
FDA (686)
Funding (109)
Gene editing (3)
Generative AI (1)
Gene therapy (3)
GLP-1 (25)
Government (120)
Guidances (13)
Healthcare (1000)
Hematology (1)
HIV (1)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (2)
Immuno-oncology (3)
Indications (2)
Infectious disease (240)
Inflammatory bowel disease (4)
Influenza (1)
Intellectual property (9)
Interviews (3)
IPO (1162)
Job creations (269)
Job search strategy (9)
Kidney disease (2)
Layoffs (11)
Legal (603)
Liver cancer (1)
Longevity (2)
Lung cancer (21)
Lymphoma (3)
Machine learning (5)
Management (1)
Manufacturing (40)
Medical device (749)
Medtech (759)
Mergers & acquisitions (1875)
Metabolic disorders (16)
mRNA (5)
Multiple sclerosis (4)
Neurodegenerative disease (14)
Neuropsychiatric disorders (2)
Neuroscience (160)
NextGen: Class of 2026 (268)
Non-profit (93)
Obesity (5)
Opinion (2)
Ovarian cancer (3)
Pain (12)
Pancreatic cancer (24)
Parkinson's disease (9)
Partnered (12)
Patents (30)
Patient recruitment (23)
People (4265)
Pharmaceutical (4)
Phase 1 (826)
Phase 2 (1358)
Phase 3 (796)
Pipeline (337)
Postmarket research (65)
Preclinical (361)
Press Release (2)
Prostate cancer (20)
Psychedelics (3)
Radiopharmaceuticals (25)
Rare diseases (43)
Real estate (278)
Recruiting (1)
Regulatory (981)
Reports (22)
Research institute (72)
Rett syndrome (3)
RNA editing (3)
Schizophrenia (5)
Series A (8)
Series B (4)
Service/supplier (2)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (197)
State (1)
Supply chain (3)
Vaccines (33)
Venture capital (1)
Weight loss (2)
Women's health (3)
Date
Last 7 days (22)
Last 30 days (114)
Last 365 days (1561)
2026 (1135)
2025 (1652)
2024 (1918)
2023 (2176)
2022 (2941)
2021 (3665)
2020 (2866)
2019 (1931)
2018 (1504)
2017 (1414)
2016 (1376)
2015 (1693)
2014 (1424)
2013 (1156)
2012 (1323)
2011 (1315)
2010 (1428)
Location
Africa (38)
Alabama (2)
Arizona (14)
Asia (1419)
Australia (129)
California (383)
Canada (1228)
China (10)
Colorado (18)
Connecticut (7)
Delaware (11)
Europe (2747)
Florida (96)
Georgia (10)
Idaho (3)
Illinois (42)
India (6)
Indiana (52)
Japan (29)
Kansas (3)
Kentucky (2)
Louisiana (3)
Maryland (28)
Massachusetts (242)
Michigan (55)
Minnesota (74)
Montana (9)
Nebraska (3)
Nevada (10)
New Hampshire (11)
New Jersey (282)
New Mexico (7)
New York (223)
North Carolina (80)
North Dakota (1)
Northern California (189)
Ohio (19)
Oklahoma (4)
Oregon (1)
Pennsylvania (211)
Puerto Rico (1)
South America (51)
South Carolina (1)
Southern California (120)
Tennessee (10)
Texas (215)
United States (2128)
Utah (6)
Virginia (8)
Washington D.C. (1)
Washington State (21)
Wisconsin (44)
Wyoming (3)
38,420 Results for "intelgenx corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
COSCIENS ACQUIRES NUALTIS CORP.
September 10, 2026
·
19 min read
Studies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® Platform
IntelGenx Corp. announced positive results from a proof-of-concept study to assess the palatability, owner-perceived acceptability, and ease of repeated administration of IntelGenx’s VetaFilm® platform in healthy dogs and cats.
February 5, 2024
·
4 min read
Press Releases
Protect Pharmaceutical Corp. Announces Closing of Environmental Infrastructure Acquisitions
August 18, 2026
·
5 min read
Press Releases
Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
August 28, 2026
·
3 min read
Press Releases
PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures
September 23, 2026
·
3 min read
Business
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the three- and twelve-month periods ended December 31, 2023.
March 21, 2024
·
7 min read
Press Releases
Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options
August 25, 2026
·
5 min read
Press Releases
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
July 21, 2026
·
3 min read
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC (“Xiromed”), has received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) regarding its resubmitted abbreviated new drug application (“ANDA”) for Buprenorphine Buccal Film.
April 5, 2024
·
3 min read
Press Releases
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
June 26, 2026
·
4 min read
1 of 3,842
Next
